NVO news, real time NVO stock news, Novo-Nordisk A/S news today

News

NVO

48.93

+0.39%

0.19

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision

Reuters · 1h ago

Novo Nordisk price target lowered to DKK 360 from DKK 415 at Berenberg

TipRanks · 3h ago

BUZZ-Hims & Hers falls, set for tenth straight day of losses

Reuters · 3h ago

Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market

Benzinga · 4h ago

Novo Nordisk Expands GLP-1 Ambitions With Completed Liver and Alcohol Use Trial

TipRanks · 5h ago

Novo said to eye Ireland to produce Wegovy pill for international markets

Seeking Alpha · 5h ago

Berenberg Bank Sticks to Their Buy Rating for Novo Nordisk (NVO)

TipRanks · 10h ago

Analysts Offer Insights on Healthcare Companies: Avantor (AVTR), Novo Nordisk (NVO) and Neurocrine (NBIX)

TipRanks · 10h ago

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Reuters · 10h ago

Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.

The Motley Fool · 11h ago

Novo Nordisk Faces Legal And FDA Challenges As Valuation Gap Widens

Simply Wall St · 11h ago

Novo Nordisk upgraded to Hold from Underperform at Jefferies

TipRanks · 12h ago

Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs

Benzinga · 12h ago

*Novo Nordisk Raised to Hold From Underperform by Jefferies

Dow Jones · 13h ago

*Novo Nordisk Target Raised to DKK275 From DKK270 by Jefferies

Dow Jones · 13h ago

Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU)

TipRanks · 14h ago

Novo Nordisk said to follow Lilly and sell obesity shot Wegovy in vial

Seeking Alpha · 17h ago

Correction to Novo Nordisk TV Ad Article on Feb. 9

Dow Jones · 1d ago

ESIH, XSDR, HLTH: These ETFs Provide Exposure to Europe’s Top Healthcare Companies

TipRanks · 1d ago

Novo Nordisk CFO Sells DKK 8.4 Million in Company Shares

TipRanks · 1d ago

Webull provides a variety of real-time NVO stock news. You can receive the latest news about Novo-Nordisk A/S through multiple platforms. This information may help you make smarter investment decisions.

About NVO

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.